Literature DB >> 7526840

Inhibition of adenylate cyclase activity by galanin in rat insulinoma cells is mediated by the G-protein Gi3.

P de Mazancourt1, P K Goldsmith, L S Weinstein.   

Abstract

Galanin inhibits adenylate cyclase activity and insulin secretion and modulates ion channels in pancreatic beta-cells through pertussis-toxin-sensitive G-protein(s). Antibodies directed against the C-terminal region of specific G-protein alpha-subunits were used to determine which G-protein(s) couple galanin receptors to inhibition of adenylate cyclase in the rat insulinoma cell line RINm5F. Preincubation of membranes with EC antibody (anti-alpha i3) decreased the inhibition of forskolin-stimulated adenylate cyclase activity by galanin (100 nM) by 45% compared with control IgG (P < 0.05) whereas preincubation with AS (anti-alpha i1, alpha i2) or GO (anti-alpha o) antibodies had no significant effect. To confirm these results, RINm5F cells were exposed intermittently over a 4-day period to phosphorothioate oligodeoxynucleotides that were either sense or antisense to alpha i1, alpha i2, alpha i3 or alpha o. Oligodeoxynucleotides antisense to alpha i2, alpha i3 and alpha o specifically decreased the levels of the targeted alpha-subunit in membranes. alpha i1 was undetectable in these cells. Inhibition of adenylate cyclase activity by galanin was largely abolished in membranes from cells exposed to the oligodeoxynucleotide antisense to alpha i3, whereas all other oligodeoxynucleotides had no significant effect on this pathway. Indirect immunofluorescence and immunoblotting of specific membrane fractions with EC antibody show significant localization of alpha i3 to intracellular membrane compartments. These results suggest that Gi3 is the G protein that couples galanin receptors to inhibition of adenylate cyclase activity in RINm5F cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7526840      PMCID: PMC1137337          DOI: 10.1042/bj3030369

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  55 in total

1.  Differential degradation rates of the G protein alpha o in cultured cardiac and pituitary cells.

Authors:  S Silbert; T Michel; R Lee; E J Neer
Journal:  J Biol Chem       Date:  1990-02-25       Impact factor: 5.157

Review 2.  The GTPase superfamily: a conserved switch for diverse cell functions.

Authors:  H R Bourne; D A Sanders; F McCormick
Journal:  Nature       Date:  1990-11-08       Impact factor: 49.962

Review 3.  The GTPase superfamily: conserved structure and molecular mechanism.

Authors:  H R Bourne; D A Sanders; F McCormick
Journal:  Nature       Date:  1991-01-10       Impact factor: 49.962

4.  Antibodies to the GTP binding protein, Go, antagonize noradrenaline-induced calcium current inhibition in NG108-15 hybrid cells.

Authors:  I McFadzean; I Mullaney; D A Brown; G Milligan
Journal:  Neuron       Date:  1989-08       Impact factor: 17.173

5.  Receptor and effector interactions of Gs. Functional studies with antibodies to the alpha s carboxyl-terminal decapeptide.

Authors:  W F Simonds; P K Goldsmith; C J Woodard; C G Unson; A M Spiegel
Journal:  FEBS Lett       Date:  1989-06-05       Impact factor: 4.124

6.  Gi2 mediates alpha 2-adrenergic inhibition of adenylyl cyclase in platelet membranes: in situ identification with G alpha C-terminal antibodies.

Authors:  W F Simonds; P K Goldsmith; J Codina; C G Unson; A M Spiegel
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

7.  Galanin receptor in the rat pancreatic beta cell line Rin m 5F. Molecular characterization by chemical cross-linking.

Authors:  B Amiranoff; A M Lorinet; M Laburthe
Journal:  J Biol Chem       Date:  1989-12-05       Impact factor: 5.157

8.  Galanin inhibits insulin secretion by direct interference with exocytosis.

Authors:  S Ullrich; C B Wollheim
Journal:  FEBS Lett       Date:  1989-04-24       Impact factor: 4.124

9.  Structure of the human gene and two rat cDNAs encoding the alpha chain of GTP-binding regulatory protein Go: two different mRNAs are generated by alternative splicing.

Authors:  T Tsukamoto; R Toyama; H Itoh; T Kozasa; M Matsuoka; Y Kaziro
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

10.  Targeting of chimeric G alpha i proteins to specific membrane domains.

Authors:  J B de Almeida; E J Holtzman; P Peters; L Ercolani; D A Ausiello; J L Stow
Journal:  J Cell Sci       Date:  1994-03       Impact factor: 5.285

View more
  5 in total

1.  Go2 G protein mediates galanin inhibitory effects on insulin release from pancreatic β cells.

Authors:  Guanghua Tang; Ying Wang; Sangeun Park; Neil S Bajpayee; Diana Vi; Yoshiko Nagaoka; Lutz Birnbaumer; Meisheng Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

2.  Direct control of a large conductance K(+)-selective channel by G-proteins in adrenal chromaffin granule membranes.

Authors:  N Arispe; P De Mazancourt; E Rojas
Journal:  J Membr Biol       Date:  1995-09       Impact factor: 1.843

Review 3.  Galanin--a neuropeptide with inhibitory actions.

Authors:  K Kask; U Langel; T Bartfai
Journal:  Cell Mol Neurobiol       Date:  1995-12       Impact factor: 5.046

4.  Masked excitatory action of noradrenaline on rat islet beta-cells via activation of phospholipase C.

Authors:  Sechiko Suga; Kyoko Nakano; Teruko Takeo; Tomohiro Osanai; Yoshiji Ogawa; Soroku Yagihashi; Takahiro Kanno; Makoto Wakui
Journal:  Pflugers Arch       Date:  2003-10-24       Impact factor: 3.657

Review 5.  The Galaninergic System: A Target for Cancer Treatment.

Authors:  Manuel Lisardo Sánchez; Rafael Coveñas
Journal:  Cancers (Basel)       Date:  2022-08-01       Impact factor: 6.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.